Clinical Effectiveness of Different Technologies for Diabetes in Pregnancy: Systematic Literature Review

Overview

Journal J Med Internet Res

Publisher JMIR Publications

Specialty Medical Informatics

Date 2021 Apr 28

PMID 33908894

Citations 5

Authors

Claudia Eberle

Maxine Loehnert

Stefanie Stichling

Affiliations

Soon will be listed here.

Abstract

Background: Hyperglycemia in pregnancy occurs worldwide and is closely associated with health issues in women and their offspring, such as pregnancy and birth complications, respectively, as well as comorbidities, such as metabolic and cardiovascular diseases. To optimize the management of diabetic pregnancies, sustainable strategies are urgently needed. Investigation of constantly evolving technologies for diabetes that help to manage pregnancy and health is required.

Objective: We aimed to conduct a systematic review to assess the clinical effectiveness of technologies for diabetes in pregnancy.

Methods: Relevant databases including MEDLINE (PubMed), Cochrane Library, Embase, CINAHL, and Web of Science Core Collection were searched in September 2020 for clinical studies (2008-2020). Findings were organized by type of diabetes, type of technology, and outcomes (glycemic control, pregnancy- and birth-related outcomes, and neonatal outcomes). Study quality was assessed using Effective Public Health Practice Project criteria.

Results: We identified 15 randomized controlled trials, 3 randomized crossover trials, 2 cohort studies, and 2 controlled clinical trials. Overall, 9 studies focused on type 1 diabetes, 0 studies focused on gestational diabetes, and 3 studies focused on both type 1 diabetes and type 2 diabetes. We found that 9 studies were strong quality, 11 were moderate quality, and 2 were weak quality. Technologies for diabetes seemed to have particularly positive effects on glycemic control in all types of diabetes, shown by some strong and moderate quality studies. Positive trends in pregnancy-related, birth-related, and neonatal outcomes were observed.

Conclusions: Technologies have the potential to effectively improve the management of diabetes during pregnancy. Further research on the clinical effectiveness of these technologies is needed, especially in pregnant women with type 2 diabetes.

Citing Articles

Effectiveness of mHealth Apps for Maternal Health Care Delivery: Systematic Review of Systematic Reviews.

Ameyaw E, Amoah P, Ezezika O J Med Internet Res. 2024; 26():e49510.

PMID: 38810250 PMC: 11170050. DOI: 10.2196/49510.

The role of technology in the care of diabetes mellitus in pregnancy: an expert review.

Thayer S, Williams K, Lawlor M AJOG Glob Rep. 2023; 3(3):100245.

PMID: 37645646 PMC: 10461241. DOI: 10.1016/j.xagr.2023.100245.

Diabetes and pregnancy study (DAPSY): a 10-year single-center cohort study of pregnancies affected by diabetes.

Kapustin R, Kopteeva E, Tiselko A, Alekseenkova E, Korenevsky A, Shelaeva E Arch Gynecol Obstet. 2023; 309(6):2643-2651.

PMID: 37594491 DOI: 10.1007/s00404-023-07187-2.

Smartphone Apps for Surveillance of Gestational Diabetes: Scoping Review.

Smyth S, Curtin E, Tully E, Molphy Z, Breathnach F JMIR Diabetes. 2022; 7(4):e38910.

PMID: 36409549 PMC: 9723973. DOI: 10.2196/38910.

Comparison of insulin requirements across gestation in women with hyperglycemia in pregnancy: A prospective cohort study.

Rao C, Ping F Front Endocrinol (Lausanne). 2022; 13:1013663.

PMID: 36339424 PMC: 9633005. DOI: 10.3389/fendo.2022.1013663.

References

Acosta G, Brown S, Zand A, Kansara A, Sadhu A . USA Vs Europe: Who Is Leading the Diabetes Tech Race?. Curr Diab Rep. 2019; 19(11):128. DOI: 10.1007/s11892-019-1237-z. View

Borgen I, Smastuen M, Jacobsen A, Garnweidner-Holme L, Fayyad S, Noll J . Effect of the Pregnant+ smartphone application in women with gestational diabetes mellitus: a randomised controlled trial in Norway. BMJ Open. 2019; 9(11):e030884. PMC: 6858205. DOI: 10.1136/bmjopen-2019-030884. View

Ly T, Nicholas J, Retterath A, Lim E, Davis E, Jones T . Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013; 310(12):1240-7. DOI: 10.1001/jama.2013.277818. View

Feig D, Corcoy R, Donovan L, Murphy K, Barrett J, Sanchez J . Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care. 2018; 41(12):2471-2479. DOI: 10.2337/dc18-1437. View

Bellamy L, Casas J, Hingorani A, Williams D . Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009; 373(9677):1773-9. DOI: 10.1016/S0140-6736(09)60731-5. View

Feig D, Donovan L, Corcoy R, Murphy K, Amiel S, Hunt K . Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017; 390(10110):2347-2359. PMC: 5713979. DOI: 10.1016/S0140-6736(17)32400-5. View

Eberle C, Ament C . Diabetic and metabolic programming: mechanisms altering the intrauterine milieu. ISRN Pediatr. 2012; 2012:975685. PMC: 3508573. DOI: 10.5402/2012/975685. View

Stewart Z, Wilinska M, Hartnell S, ONeil L, Rayman G, Scott E . Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial. Diabetes Care. 2018; 41(7):1391-1399. DOI: 10.2337/dc17-2534. View

Yang P, Lo W, He Z, Xiao X . Medical nutrition treatment of women with gestational diabetes mellitus by a telemedicine system based on smartphones. J Obstet Gynaecol Res. 2018; 44(7):1228-1234. DOI: 10.1111/jog.13669. View

10.

Secher A, Ringholm L, Andersen H, Damm P, Mathiesen E . The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013; 36(7):1877-83. PMC: 3687305. DOI: 10.2337/dc12-2360. View

11.

. 7. Diabetes Technology: . Diabetes Care. 2019; 43(Suppl 1):S77-S88. DOI: 10.2337/dc20-S007. View

12.

McAdams B, Rizvi A . An Overview of Insulin Pumps and Glucose Sensors for the Generalist. J Clin Med. 2016; 5(1). PMC: 4730130. DOI: 10.3390/jcm5010005. View

13.

Armijo-Olivo S, Stiles C, Hagen N, Biondo P, Cummings G . Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2010; 18(1):12-8. DOI: 10.1111/j.1365-2753.2010.01516.x. View

14.

Mackillop L, Hirst J, Bartlett K, Birks J, Clifton L, Farmer A . Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018; 6(3):e71. PMC: 5883074. DOI: 10.2196/mhealth.9512. View

15.

Cordua S, Secher A, Ringholm L, Damm P, Mathiesen E . Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes - observations from a randomized controlled trial. Diabet Med. 2013; 30(11):1374-81. DOI: 10.1111/dme.12246. View

16.

Jotic A, Milicic T, Lalic K, Lukic L, Macesic M, Stanarcic Gajovic J . Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes. Diabetes Ther. 2020; 11(4):845-858. PMC: 7136374. DOI: 10.1007/s13300-020-00780-7. View

17.

Elleri D, Dunger D, Hovorka R . Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Med. 2011; 9:120. PMC: 3229449. DOI: 10.1186/1741-7015-9-120. View

18.

Miremberg H, Ben-Ari T, Betzer T, Raphaeli H, Gasnier R, Barda G . The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial. Am J Obstet Gynecol. 2018; 218(4):453.e1-453.e7. DOI: 10.1016/j.ajog.2018.01.044. View

19.

Gutaj P, Zawiejska A, Brazert J, Wender-Ozegowska E . Association between preconceptional treatment with insulin pumps and improved metabolic status in early pregnancy in women with type 1 diabetes. Pol Arch Med Wewn. 2015; 125(5):329-36. DOI: 10.20452/pamw.2830. View

20.

Kernaghan D, Farrell T, Hammond P, Owen P . Fetal growth in women managed with insulin pump therapy compared to conventional insulin. Eur J Obstet Gynecol Reprod Biol. 2007; 137(1):47-9. DOI: 10.1016/j.ejogrb.2007.05.006. View